TOP STORIES
A GlaxoSmithKline clinical trial has failed to show that the company’s Breo inhaler extends life in patients with chronic obstructive pulmonary disease, which now knocks out hopes of a major sales boost for the product.
Ronny Gal, an analyst at Bernstein, predicted the impact of the disappointing clinical trial would be larger in Europe because the results would show that it’s not worth a higher price tag given lower cost alternatives. It’s a big deal as respiratory drugs amount to one-quarter of GSK’s sales. — Financial Times
According to a study published online in JAMA, nearly 50 percent of adults living in the U.S. now have Type 1 diabetes, Type 2 diabetes or pre-diabetes. — Forbes
LIFE SCIENCES
Johnson & Johnson plans to launch a JLABS incubator in Toronto, Ontario. Dubbed JLABS @ Toronto, the incubator can house up to 50 life science start-ups, and is expected to open in spring 2016. — BioCentury
Biogen has bought full access to Mitsubishi Tanabe’s MT-1303, an experimental oral compound with potential in autoimmune indications. The deal that could be worth more than $500 million. — Pharma Times
PAYERS-PROVIDERS
Columbus (Ga.) Regional Healthcare System has agreed to pay $25 million, which will be divided between the federal government and the state of Georgia, to resolve allegations it violated the False Claims Act by submitting claims to government healthcare programs in violation of Stark Law. Under the agreement, the system has also agreed to additional contingent payments not to exceed $10 million. — Department of Justice
TECH
Today is the day that Apple lifts the veil of its latest product updates. Although it doesn’t look like healthcare figures directly into the event this time, any change to its iPhones are worth checking out given how much healthcare companies use Apple products. Here are some tips on where to view the event. — ZDNet
If lawsuits were love letters, people would be gossiping like crazy about Fitbit and Jawbone. After Jawbone filed two lawsuits against Fitbit, the public company is now suing Jawbone for patent infringement. — MobiHealthNews
POLITICS
The House passed legislation that will reauthorize programs to conduct medical research and transplants using stem cells from bone marrow and umbilical cord blood.
Passed by voice vote after only about ten minutes of debate, the bill authorizes $23 million annually for the National Cord Blood Inventory Program and $30 million per year for the C.W. Bill Young Cell Transportation Program through fiscal 2020. — The Hill
A LITTLE BIT EXTRA
Despite WI-FI, the internet is still delivered around the world mostly through cables deep below the sea. This video illustrates what that system really looks like.